|
|
Vol. 11.17 – 05 October, 2026
|
|
|
|
|
|
|
|
|
The authors sought to elucidate the THO complex subunit 5 (THOC5)-dependent post-transcriptional regulatory mechanisms that control vascular smooth muscle cell transdifferentiation and contribute to chronic kidney disease-associated vascular calcification. [Kidney International]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
|
|
Scientists identified an oxidative stress‑mediated Sirtuin 3 (Sirt3)/YME1-like 1 ATPase (YME1L1) acetylation axis, with YME1L1‑K237 as the critical acetylation switch, as a novel driver of PANoptosis in selenium‑deficient myocardium.
[The Journal of Nutritional Biochemistry]
|
|
|
|
|
|
The authors evaluated the electrophysiological effects of per- and polyfluoroalkyl substances in hiPSC- derived cardiomyocytes using multielectrode array analysis.
[Environmental Toxicology and Pharmacology]
|
|
|
|
|
|
Researchers performed integrated multi-omic profiling to identify molecular pathways and regulatory programs associated with hPSC-derived cardiomyocytes maturation during long-term culture.
[Journal of Molecular and Cellular Cardiology]
|
|
|
|
|
|
Scientists investigated the function and molecular mechanism of miR-454-3p in sepsis-induced cardiomyopathy, along with its potential clinical utility.
[Internal and Emergency Medicine]
|
|
|
|
|
|
|
|
Investigators studied the ability to guide muscle cell development using femtosecond-laser-induced topography on standard culture plates.
[Advanced Science]
|
|
|
|
|
|
The authors identified the intramuscular fat fraction, rather than perimuscular fat fraction, as an independent determinant of trunk muscle strength.
[Advanced Science]
|
|
|
|
|
|
Researchers addressed the dynamics of centrosomes, which are key organelles for cell proliferation, during myogenic differentiation and dedifferentiation in a cross-species comparative setting.
[NPJ Regenerative Medicine]
|
|
|
|
|
|
Scientists investigated the mechanism by which intracellular calcium overload impairs myogenic differentiation and muscle regeneration.
[Experimental & Molecular Medicine]
|
|
|
|
|
|
Investigators developed a bioengineered skeletal muscle construct by seeding human muscle progenitor cells onto a decellularized skeletal muscle scaffold to regenerate damaged pelvic muscle tissues.
[Acta Biomaterialia]
|
|
|
|
|
|
|
|
Researchers investigated the signal transduction mechanisms linking β2-adrenoceptor activation to extracellular signal-regulated kinase1/2 activity and cell migration in vascular smooth muscle.
[Biochemical Pharmacology]
|
|
|
|
|
|
Investigators established an angiotensin II (AngII)-induced vascular smooth muscle cell (VSMC) injury model by treating VSMCs with AngII. They found histone lactylation-upregulated CCAAT enhancer binding protein beta (CEBPB) transcriptionally activated CXCL12 and p21. [Cellular Signalling]
|
|
|
|
|
|
|
|
Scientists group hereditary neuromuscular diseases by the functional consequence of the causal mutation, loss-of-function or gain-of-function, and by the pathogenic process affected.
[Molecular Therapy – Nucleic Acids]
|
|
|
|
|
|
The authors summarize recent applications of CRISPR technologies in smooth muscle biology, with a primary focus on vascular diseases.
[Vascular Pharmacology]
|
|
|
|
|
|
Scientists provide a comprehensive framework for addressing barriers and strategies that may support the development of safe, affordable, and structurally relevant cultured meat products. [Food Science of Animal Resources]
|
|
|
|
|
|
|
|
Bristol Myers Squibb announced that the US FDA approved CAMZYOS® (mavacamten) for the treatment of symptomatic obstructive hypertrophic cardiomyopathy to improve functional capacity and symptoms in adults and pediatric patients weighing 30 kg (66 lbs) or more.
[Bristol Myers Squibb]
|
|
|
|
|
|
Secretome Therapeutics announced the initiation of THRIVE-2, a Phase II clinical study evaluating STM-01 in patients with Duchenne muscular dystrophy.
[Secretome Therapeutics]
|
|
|
|
|
|
A Wayne State University research team was awarded a $5.7 million grant focused on discovering the biological mechanisms that may help explain why some lean people develop insulin resistance while some people with obesity remain sensitive to insulin. [Wayne State University]
|
|
|
|
|
|
JCR Pharmaceuticals announced that the Ministry of Health, Labour and Welfare of Japan granted orphan drug designation to givinostat, an investigational drug for the treatment of Duchenne muscular dystrophy. [JCR Pharmaceuticals]
|
|
|
|
|
|
|
|
November 16-17, 2026 Philadelphia, Pennsylvania, United States
|
|
|
|
|
|
|
|
|
|
|
Mayo Clinic – Phoenix, Arizona, United States
|
|
|
|
|
|
|
National Institutes of Health – Bethesda, Maryland, United States
|
|
|
|
|
|
|
Weill Cornell Medicine – New York City, New York, United States
|
|
|
|
|
|
|
La Jolla Institute for Immunology – San Diego, California, United States
|
|
|
|
|
|
|
Columbia University Irving Medical Center – New York City, New York, United States
|
|
|
|
|
|